Our structure
Executive Board
Nicoletta Luppi
President (MSD)
Lorenzo Wittum
Vice President & Treasurer (AstraZeneca)
Andreas Potthoff
(Abbott)
Basil Babychan
(Bilthoven Biologicals)
John-Kenneth Billingsley
(CSL Seqirus)
Tanja Veikkola
(GSK)
Jörg Jenewein
(Moderna)
Tobias Cousens
(Pfizer)
Florence Baron-Papillon
(Sanofi)
Walid Kandeil
(Takeda)
Juan Carlos Jaramillo
(Valneva)
Executive Office
Sibila Quilici
Executive Director
Anna Czwarno
Director, Regulatory, Manufacturing & Supply
Charlotte Vernhes
Director, Scientific and Medical Affairs
Anna Vicere
Director, Public Affairs & Access Policy
Alina Juuti
Associate Director, Communications & Policy
Ingrid Weindorfer
Project Manager
Kateryna Khmilevska
Junior Science and Regulatory Manager
Eva Antunano
Assistant Manager
Working Group Chairs
Public Affairs
Mark Canavan
Sanofi
Regulatory Affairs
Andrew Deavin
GSK
RESEARCH, INNOVATION & MEDICAL
Lucie Rochard
Sanofi
Market Access
Kathleen Grieve
MSD
Manufacturing & Supply
Niko Salo
Pfizer
NATIONAL VACCINE INDUSTRY GROUP’S TASK FORCE
Gisela Payeras Bailly
GSK